- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.54 Å
- Oligo State
- hetero-4-4-1-mer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 16 x K: POTASSIUM ION(Non-covalent)
K.2: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.3, K.8, K.9, K.14, K.15, K.20, K.21
Ligand excluded by PLIPK.3: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.4, K.8, K.9, K.10, K.14, K.15, K.16, K.20, K.21, K.22
Ligand excluded by PLIPK.4: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.5, K.9, K.10, K.11, K.15, K.16, K.17, K.21, K.22, K.23
Ligand excluded by PLIPK.5: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.10, K.11, K.16, K.17, K.22, K.23
Ligand excluded by PLIPK.8: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.2, K.3, K.9, K.14, K.15, K.20, K.21
Ligand excluded by PLIPK.9: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.3, K.4, K.8, K.10, K.14, K.15, K.16, K.20, K.21, K.22
Ligand excluded by PLIPK.10: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.4, K.5, K.9, K.11, K.15, K.16, K.17, K.21, K.22, K.23
Ligand excluded by PLIPK.11: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.5, K.10, K.16, K.17, K.22, K.23
Ligand excluded by PLIPK.14: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.2, K.3, K.8, K.9, K.15, K.20, K.21
Ligand excluded by PLIPK.15: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.3, K.4, K.8, K.9, K.10, K.14, K.16, K.20, K.21, K.22
Ligand excluded by PLIPK.16: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.4, K.5, K.9, K.10, K.11, K.15, K.17, K.21, K.22, K.23
Ligand excluded by PLIPK.17: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.5, K.10, K.11, K.16, K.22, K.23
Ligand excluded by PLIPK.20: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.2, K.3, K.8, K.9, K.14, K.15, K.21
Ligand excluded by PLIPK.21: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.3, K.4, K.8, K.9, K.10, K.14, K.15, K.16, K.20, K.22
Ligand excluded by PLIPK.22: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.4, K.5, K.9, K.10, K.11, K.15, K.16, K.17, K.21, K.23
Ligand excluded by PLIPK.23: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.5, K.10, K.11, K.16, K.17, K.22
Ligand excluded by PLIP- 4 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
PGW.6: 11 residues within 4Å:- Chain B: P.377, D.378, F.380, W.381, V.384
- Chain D: T.398, I.400, K.403, I.404, S.407
- Chain F: L.201
7 PLIP interactions:4 interactions with chain D, 2 interactions with chain B, 1 interactions with chain F- Hydrophobic interactions: D:K.403, D:I.404, B:F.380, B:W.381, F:L.201
- Hydrogen bonds: D:T.398
- Salt bridges: D:K.403
PGW.12: 11 residues within 4Å:- Chain B: L.201
- Chain D: P.377, D.378, F.380, W.381, V.384
- Chain H: T.398, I.400, K.403, I.404, S.407
7 PLIP interactions:2 interactions with chain D, 4 interactions with chain H, 1 interactions with chain B- Hydrophobic interactions: D:F.380, D:W.381, H:K.403, H:I.404, B:L.201
- Hydrogen bonds: H:T.398
- Salt bridges: H:K.403
PGW.18: 11 residues within 4Å:- Chain B: T.398, I.400, K.403, I.404, S.407
- Chain F: P.377, D.378, F.380, W.381, V.384
- Chain H: L.201
7 PLIP interactions:4 interactions with chain B, 1 interactions with chain H, 2 interactions with chain F- Hydrophobic interactions: B:K.403, B:I.404, H:L.201, F:F.380, F:W.381
- Hydrogen bonds: B:T.398
- Salt bridges: B:K.403
PGW.24: 11 residues within 4Å:- Chain D: L.201
- Chain F: T.398, I.400, K.403, I.404, S.407
- Chain H: P.377, D.378, F.380, W.381, V.384
7 PLIP interactions:1 interactions with chain D, 4 interactions with chain F, 2 interactions with chain H- Hydrophobic interactions: D:L.201, F:K.403, F:I.404, H:F.380, H:W.381
- Hydrogen bonds: F:T.398
- Salt bridges: F:K.403
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Banerjee, A. et al., Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K(+) channel. Elife (2013)
- Release Date
- 2013-06-12
- Peptides
- Voltage-gated potassium channel subunit beta-2: ACEG
Potassium voltage-gated channel subfamily A member 2, Potassium voltage-gated channel subfamily B member 1: BDFH
Potassium channel toxin alpha-KTx 1.1: I - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
GE
GG
GB
HD
HF
HH
HI
Y - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.54 Å
- Oligo State
- hetero-4-4-1-mer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 16 x K: POTASSIUM ION(Non-covalent)
- 4 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Banerjee, A. et al., Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K(+) channel. Elife (2013)
- Release Date
- 2013-06-12
- Peptides
- Voltage-gated potassium channel subunit beta-2: ACEG
Potassium voltage-gated channel subfamily A member 2, Potassium voltage-gated channel subfamily B member 1: BDFH
Potassium channel toxin alpha-KTx 1.1: I - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
GE
GG
GB
HD
HF
HH
HI
Y - Membrane
-
We predict this structure to be a membrane protein.